Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 11/20 | 0.63 |
| ▸ | OPRM1 | P35372 | 9/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 7/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23375498 | 1.00 | OPRD1 (0.63) | OPRD1OPRM1ALDH1A1LMNAOPRK1 | |
| SCHEMBL24486400 | 0.86 | OPRD1 (0.63) | OPRD1OPRM1ALDH1A1LMNAOPRK1 | |
| SCHEMBL23435853 | 0.86 | OPRD1 (0.63) | OPRD1OPRM1ALDH1A1LMNAOPRK1 | |
| SCHEMBL23375500 | 0.82 | OPRD1 (0.60) | OPRD1OPRM1ALDH1A1LMNAOPRK1 | |
| SCHEMBL23357169 | 0.82 | OPRD1 (0.60) | OPRD1OPRM1ALDH1A1OPRK1 | |
| SCHEMBL23356952 | 0.82 | OPRD1 (0.60) | OPRD1OPRM1ALDH1A1OPRK1 | |
| SCHEMBL24486403 | 0.82 | OPRD1 (0.60) | OPRD1OPRM1ALDH1A1LMNAOPRK1 | |
| SCHEMBL23356955 | 0.82 | OPRD1 (0.60) | OPRD1OPRM1ALDH1A1OPRK1 | |
| SCHEMBL23435880 | 0.82 | OPRD1 (0.60) | OPRD1OPRM1ALDH1A1OPRK1 | |
| SCHEMBL21447394 | 0.82 | OPRD1 (0.60) | OPRD1OPRM1ALDH1A1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210147343-A1 | OPIOID RECEPTOR MODULATORS AND PRODUCTS AND METHODS RELATED THERETO | EPIODYNE, INC. | 2021-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210147343-A1 | OPIOID RECEPTOR MODULATORS AND PRODUCTS AND METHODS RELATED THERETO | OPRM1, OPRD1, OPRK1 | OPRD1 2/4885OPRM1 1/4885ALDH1A1 1936/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.